↓ Skip to main content

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study

Overview of attention for article published in BMC Cancer, January 2019
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
35 Mendeley